IDEXX LABORATORIES INC /DE Accounts Payable
IDEXX LABORATORIES INC /DE (IDXX) had Accounts Payable of $129.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-04
- 2026-06-30: Accounts Payable, Current $129.10M.
- 2026-03-31: Accounts Payable, Current $129.97M.
- 2025-12-31: Accounts Payable, Current $110.41M.
- 2025-09-30: Accounts Payable, Current $122.27M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $129.10M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $129.97M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $110.41M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $122.27M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $116.58M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $120.10M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $114.21M 10-K · filed 2026-02-20 |
| 2024-09-30 | $110.60M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $117.47M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $117.46M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $110.64M 10-K · filed 2025-02-21 |
| 2023-09-30 | $112.61M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $107.66M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $117.71M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $110.22M 10-K · filed 2024-02-22 |
| 2022-09-30 | $110.14M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $127.26M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $120.88M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $116.14M 10-K · filed 2023-02-16 |
| 2021-09-30 | $86.68M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $93.02M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $87.17M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $74.56M 10-K · filed 2022-02-16 |
| 2020-09-30 | $71.93M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $73.90M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $74.21M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $72.17M 10-K · filed 2021-02-12 |
| 2019-09-30 | $75.52M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $67.61M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $70.14M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $69.53M 10-K · filed 2020-02-14 |
| 2018-09-30 | $65.46M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $68.02M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $70.41M 10-Q · filed 2018-05-04 |
| 2018-01-01 | $66.97M 10-K · filed 2019-02-15 |
| 2017-12-31 | $66.97M 10-K · filed 2019-02-15 |
| 2017-09-30 | $60.58M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $58.61M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $62.25M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $60.06M 10-K · filed 2018-02-16 |
| 2016-09-30 | $44.13M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $50.09M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $52.46M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $52.65M 10-K · filed 2017-02-17 |
| 2015-09-30 | $53.61M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $58.21M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $44.18M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $44.74M 10-K · filed 2016-02-17 |
| 2014-09-30 | $58.26M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $41.42M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $42.79M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $29.94M 10-K · filed 2015-02-17 |
| 2013-09-30 | $38.13M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $37.58M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $38.72M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $35.29M 10-K · filed 2014-02-18 |
| 2012-09-30 | $31.73M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $29.71M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $40.61M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $36.55M 10-K · filed 2013-02-19 |
| 2011-09-30 | $31.03M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $29.89M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $23.33M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $22.67M 10-K · filed 2012-02-17 |
| 2010-09-30 | $25.27M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $23.19M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $19.13M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |